These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11434395)

  • 1. Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared.
    Del Ry S; Giannessi D; Clerico A
    Clin Chem Lab Med; 2001 May; 39(5):446-50. PubMed ID: 11434395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method.
    Del Ry S; Clerico A; Giannessi D; Andreassi MG; Caprioli R; Iascone MR; Ferrazzi P; Biagini A
    Scand J Clin Lab Invest; 2000 Apr; 60(2):81-90. PubMed ID: 10817394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure.
    Masson S; Vago T; Baldi G; Salio M; De Angelis N; Nicolis E; Maggioni AP; Latini R; Norbiato G; Bevilacqua M
    Clin Chem Lab Med; 2002 Aug; 40(8):761-3. PubMed ID: 12392300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices.
    Ro R; Thode HC; Taylor M; Gulla J; Tetrault E; Singer AJ
    J Emerg Med; 2011 Dec; 41(6):661-7. PubMed ID: 21620610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure.
    Feola M; Valeri L; Menditto E; Nervo E; Bianco F; Aspromonte N; Valle R; Visconti G
    J Endocrinol Invest; 2010 Sep; 33(8):554-8. PubMed ID: 20160469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method.
    Storti S; Prontera C; Emdin M; Passino C; Prati P; Fontani G; Giannelli I; Zyw L; Vittorini S; Zucchelli G; Clerico A
    Clin Chem Lab Med; 2004; 42(10):1178-85. PubMed ID: 15552278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity.
    Naik GO; Moe GW
    Clin Chem Lab Med; 2007; 45(10):1353-9. PubMed ID: 17663629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study.
    Wu AH; Packer M; Smith A; Bijou R; Fink D; Mair J; Wallentin L; Johnston N; Feldcamp CS; Haverstick DM; Ahnadi CE; Grant A; Despres N; Bluestein B; Ghani F
    Clin Chem; 2004 May; 50(5):867-73. PubMed ID: 15010423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
    Niederkofler EE; Kiernan UA; O'Rear J; Menon S; Saghir S; Protter AA; Nelson RW; Schellenberger U
    Circ Heart Fail; 2008 Nov; 1(4):258-64. PubMed ID: 19808300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population.
    Alehagen U; Lindstedt G; Levin LA; Dahlström U
    Int J Cardiol; 2005 Apr; 100(1):125-33. PubMed ID: 15820295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials.
    Franzini M; Masotti S; Prontera C; Ripoli A; Passino C; Giovannini S; Zucchelli G; Clerico A
    Clin Chim Acta; 2013 Sep; 424():287-91. PubMed ID: 23850775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI].
    Alibay Y; Schmitt C; Beauchet A; Dubourg O; Alexandre JA; Boileau C; Jondeau G; Puy H
    Ann Biol Clin (Paris); 2005; 63(1):43-9. PubMed ID: 15689311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter analytical performance evaluation of the Elecsys proBNP assay.
    Sokoll LJ; Baum H; Collinson PO; Gurr E; Haass M; Luthe H; Morton JJ; Nowatzke W; Zingler C
    Clin Chem Lab Med; 2004; 42(8):965-72. PubMed ID: 15387451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.
    Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R
    Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.